Proto Labs, Inc. (PRLB) FY2026 Q2 Balance Sheet
As of 2026-06-30
Balance Sheet
As of 2026-06-30
Swipe to see the full flow
Chart details
Proto Labs, Inc. (PRLB) FY2026 Q2 Balance Sheet
Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.
- Assets
- 791,298,000 US dollars
- Current assets
- 266,243,000 US dollars
- Non-current assets
- 525,055,000 US dollars
- Liabilities
- 99,565,000 US dollars
- Current liabilities
- 73,204,000 US dollars
- Non-current liabilities
- 26,361,000 US dollars
- Equity
- 691,733,000 US dollars
- Cash and cash equivalents
- 127,918,000 US dollars
- Accounts receivable, net of allowance for credit losses of $3,022 and $2,668 as of June 30, 2026, and December 31, 2025, respectively
- 95,074,000 US dollars
- Inventory
- 15,413,000 US dollars
- Short-term marketable securities
- 14,858,000 US dollars
- Prepaid expenses and other current assets
- 11,590,000 US dollars
- Income taxes receivable
- 1,390,000 US dollars
- Goodwill
- 273,991,000 US dollars
- Property and equipment, net
- 208,329,000 US dollars
- Long-term marketable securities
- 20,120,000 US dollars
- Other intangible assets, net
- 16,606,000 US dollars
- Other long-term assets
- 4,456,000 US dollars
- Operating lease assets
- 1,263,000 US dollars
- Finance lease assets
- 290,000 US dollars
- Accrued liabilities and other
- 31,776,000 US dollars
- Accounts payable
- 21,542,000 US dollars
- Accrued compensation
- 18,830,000 US dollars
- Current operating lease liabilities
- 929,000 US dollars
- Current finance lease liabilities
- 127,000 US dollars
- Long-term deferred tax liabilities
- 20,625,000 US dollars
- Other long-term liabilities
- 4,551,000 US dollars
- Long-term operating lease liabilities
- 1,185,000 US dollars
- Additional paid-in capital
- 460,671,000 US dollars
- Retained earnings
- 254,326,000 US dollars
- Common stock, $0.001 par value, authorized 150,000,000 shares; issued and outstanding 23,921,897 and 23,627,422 shares as of June 30, 2026, and December 31, 2025, respectively
- 24,000 US dollars
- Preferred stock, $0.001 par value, authorized 10,000,000 shares; issued and outstanding 0 shares as of June 30, 2026, and December 31, 2025, respectively
- 0 US dollars
- Accumulated other comprehensive loss
- negative 23,288,000 US dollars
- Gross equity (calculated)
- 715,021,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.
Chart connections
- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.

Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG
Product waitlist
Health Check and Teardown for your own company
A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!
